Somerville, MA, United States of America

Tanvi Deshpande

USPTO Granted Patents = 2 

Average Co-Inventor Count = 5.0

ph-index = 1


Location History:

  • Somerville, MA (US) (2020)
  • Baltimore, MD (US) (2020)

Company Filing History:


Years Active: 2020

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Tanvi Deshpande: Pioneering Treatments for Sickle Cell Disease

Introduction

Tanvi Deshpande is an accomplished inventor based in Somerville, MA (US). She has made significant contributions to the field of pharmacology, particularly in developing treatments for sickle cell disease. With a total of 2 patents, her work is paving the way for new therapeutic options.

Latest Patents

One of her latest patents focuses on ester nitrates derivatives of aromatic aldehydes with multiple pharmacologic properties to treat sickle cell disease. This invention provides new aromatic aldehyde compounds that exhibit greater potency in increasing the affinity of hemoglobin for oxygen. Additionally, these compounds demonstrate enhanced effectiveness in preventing sickling and possess other pharmacologic properties that alleviate various symptoms associated with sickle cell disease. The invention also outlines methods for treating individuals with sickle cell disease by administering these innovative compounds.

Career Highlights

Tanvi Deshpande is affiliated with Virginia Commonwealth University, where she continues her research and development efforts. Her work is characterized by a commitment to improving patient outcomes through innovative solutions.

Collaborations

She collaborates with esteemed colleagues, including Martin K. Safo and Yan Zhang, who contribute to her research endeavors and enhance the impact of her inventions.

Conclusion

Tanvi Deshpande's innovative work in developing treatments for sickle cell disease exemplifies her dedication to advancing medical science. Her contributions are vital in the ongoing fight against this challenging condition.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…